Literature DB >> 17440987

Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.

Mikala Egeblad1, H-C Jennifer Shen, Danielle J Behonick, Lisa Wilmes, Alexandra Eichten, Lidiya V Korets, Farrah Kheradmand, Zena Werb, Lisa M Coussens.   

Abstract

Recessive inactivating mutations in human matrix metalloproteinase 2 (MMP2, gelatinase A) are associated with syndromes that include abnormal facial appearance, short stature, and severe bone loss. Mmp2(-/-) mice have only mild aspects of these abnormalities, suggesting that MMP2 function is redundant during skeletal development in the mouse. Here, we report that Mmp2(-/-) mice with additional mutations that render type I collagen resistant to collagenase-mediated cleavage to TC(A) and TC(B) fragments (Col1a1(r/r) mice) have severe developmental defects resembling those observed in MMP2-null humans. Composite Mmp2(-/-);Col1a1(r/r) mice were born in expected Mendelian ratios but were half the size of wild-type, Mmp2(-/-), and Col1a1(r/r) mice and failed to thrive. Furthermore, composite Mmp2(-/-);Col1a1(r/r) animals had very abnormal craniofacial features with shorter snouts, bulging skulls, incompletely developed calvarial bones and unclosed cranial sutures. In addition, trabecular bone mass was reduced concomitant with increased numbers of bone-resorbing osteoclasts and osteopenia. In vitro, MMP2 had a unique ability among the collagenolytic MMPs to degrade mutant collagen, offering a possible explanation for the genetic interaction between Mmp2 and Col1a1(r). Thus, because mutations in the type I collagen gene alter the phenotype of mice with null mutations in Mmp2, we conclude that type I collagen is an important modifier gene for Mmp2. Developmental Dynamics 236:1683-1693, 2007. (c) 2007 Wiley-Liss, Inc. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440987      PMCID: PMC2581616          DOI: 10.1002/dvdy.21159

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  45 in total

1.  Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I.

Authors:  Z Zhou; S S Apte; R Soininen; R Cao; G Y Baaklini; R W Rauser; J Wang; Y Cao; K Tryggvason
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 2.  The collagen receptor integrins have distinct ligand recognition and signaling functions.

Authors:  J Heino
Journal:  Matrix Biol       Date:  2000-08       Impact factor: 11.583

3.  Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.

Authors:  J A Martignetti; A A Aqeel; W A Sewairi; C E Boumah; M Kambouris; S A Mayouf; K V Sheth; W A Eid; O Dowling; J Harris; M J Glucksman; S Bahabri; B F Meyer; R J Desnick
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

4.  Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI.

Authors:  S C Partridge; G C McKinnon; R G Henry; N M Hylton
Journal:  J Magn Reson Imaging       Date:  2001-10       Impact factor: 4.813

Review 5.  Modifier genes in mice and humans.

Authors:  J H Nadeau
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

6.  Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells.

Authors:  S L Cheng; C F Lai; A Fausto; M Chellaiah; X Feng; K P McHugh; S L Teitelbaum; R Civitelli; K A Hruska; F P Ross; L V Avioli
Journal:  J Cell Biochem       Date:  2000-03       Impact factor: 4.429

Review 7.  New form of idiopathic osteolysis: nodulosis, arthropathy and osteolysis (NAO) syndrome.

Authors:  S M Al-Mayouf; M Majeed; C Hugosson; S Bahabri
Journal:  Am J Med Genet       Date:  2000-07-03

8.  Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen.

Authors:  W Zhao; M H Byrne; Y Wang; S M Krane
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

9.  A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality.

Authors:  V Mann; E E Hobson; B Li; T L Stewart; S F Grant; S P Robins; R M Aspden; S H Ralston
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

10.  Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells.

Authors:  E Stringa; V Knäuper; G Murphy; J Gavrilovic
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

View more
  21 in total

Review 1.  The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Gregg B Fields; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 2.  Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

Authors:  Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.

Authors:  Nathalie Ortega; Ke Wang; Napoleone Ferrara; Zena Werb; Thiennu H Vu
Journal:  Dis Model Mech       Date:  2010-02-08       Impact factor: 5.758

4.  Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis.

Authors:  Signe Ingvarsen; Astrid Porse; Charlotte Erpicum; Ludovic Maertens; Henrik J Jürgensen; Daniel H Madsen; Maria C Melander; Henrik Gårdsvoll; Gunilla Høyer-Hansen; Agnès Noel; Kenn Holmbeck; Lars H Engelholm; Niels Behrendt
Journal:  J Biol Chem       Date:  2013-02-14       Impact factor: 5.157

5.  Detection of gelatinolytic activity in developing basement membranes of the mouse embryo head by combining sensitive in situ zymography with immunolabeling.

Authors:  Nikolaos Gkantidis; Christos Katsaros; Matthias Chiquet
Journal:  Histochem Cell Biol       Date:  2012-06-12       Impact factor: 4.304

6.  The podosomal-adaptor protein SH3PXD2B is essential for normal postnatal development.

Authors:  Mao Mao; Daniel R Thedens; Bo Chang; Belinda S Harris; Qing Yin Zheng; Kenneth R Johnson; Leah Rae Donahue; Michael G Anderson
Journal:  Mamm Genome       Date:  2009-08-08       Impact factor: 2.957

7.  Stromal regulation of vessel stability by MMP14 and TGFbeta.

Authors:  Nor E Sounni; Kerstin Dehne; Leon van Kempen; Mikala Egeblad; Nesrine I Affara; Ileana Cuevas; Jane Wiesen; Simon Junankar; Lidiya Korets; Jake Lee; Jennifer Shen; Charlotte J Morrison; Christopher M Overall; Stephen M Krane; Zena Werb; Nancy Boudreau; Lisa M Coussens
Journal:  Dis Model Mech       Date:  2010-03-11       Impact factor: 5.758

8.  Adipogenic histone mark regulation by matrix metalloproteinase 14 in collagen-rich microenvironments.

Authors:  Kaori Sato-Kusubata; Yibin Jiang; Yoko Ueno; Tae-Hwa Chun
Journal:  Mol Endocrinol       Date:  2011-03-24

9.  Candidate Gene Analyses of Skeletal Variation in Malocclusion.

Authors:  C S G da Fontoura; S F Miller; G L Wehby; B A Amendt; N E Holton; T E Southard; V Allareddy; L M Moreno Uribe
Journal:  J Dent Res       Date:  2015-04-24       Impact factor: 6.116

10.  Endogenous human microRNAs that suppress breast cancer metastasis.

Authors:  Sohail F Tavazoie; Claudio Alarcón; Thordur Oskarsson; David Padua; Qiongqing Wang; Paula D Bos; William L Gerald; Joan Massagué
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.